Protein kinase C-dependent anti-apoptotic mechanism that is associated with high sensitivity to anti-Fas antibody in ovarian cancer cell lines

Cancer Letters

Volumn 140, Issue 1-2, 1999, Pages 113-119

  Hayakawa, Akemi ^a   Yokoyama, Itsuo ^a   Tajiri, Hisao ^b   Okamoto, Tomomitsu ^a   Nakashima, Izumi ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b National Cancer Center   (Japan)

Author keywords

Apoptosis; Fas receptor; Human ovarian cancer

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; ANTIBODY; CALCIMYCIN; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; DNA FRAGMENT; FAS ANTIBODY; FAS ANTIGEN; N (2 GUANIDINOETHYL) 5 ISOQUINOLINESULFONAMIDE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; PROTEIN KINASE C ACTIVATOR; PROTEIN KINASE C INHIBITOR; SPHINGOMYELIN PHOSPHODIESTERASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL SPECIFICITY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ANTIBODIES; ANTIGENS, CD95; APOPTOSIS; CALCIMYCIN; CELL DIVISION; CERAMIDES; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DNA FRAGMENTATION; ENZYME INHIBITORS; FEMALE; FLOW CYTOMETRY; HUMANS; ISOQUINOLINES; OVARIAN NEOPLASMS; PROTEIN KINASE C; SIGNAL TRANSDUCTION; SPHINGOMYELIN PHOSPHODIESTERASE; SULFONAMIDES; TETRADECANOYLPHORBOL ACETATE; TETRAZOLIUM SALTS; THIAZOLES; TUMOR CELLS, CULTURED;

EID: 0032972530     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00062-2     Document Type: Article

References (27)

1. Yonehara S., Ishii A., Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169:1989;1747-1756.
2. Suda T., Takahashi T., Glstein P., Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 75:1993;1169-1178.
3. 2+-independent T cell-mediated cytotoxicity. J. Exp. Med. 177:1993;195-200.
4. Suda T., Nagata S. Purification and characterization of the Fas-ligand that induces apoptosis. J. Exp. Med. 179:1994;873-879.
5. Suda T., Okazaki T., Naito Y., Yokota T., Arai N., Ozaki S., Nakao K., Nagata S. Expression of the Fas ligand in cell of T cell lineage. J. Immunol. 154:1995;3806-3813.
6. Ormerod M.G., O'Neil C.E., Robertson D., Harrap K.R. Cisplatin induces apoptosis in a human ovarian carcinoma cell line without concomitant internucleosomal degradation of DNA. Exp. Cell Res. 211:1994;231-237.
7. Borner M.M., Myers C.E., Sartor O., Sei Y., Toko T., Trepel J.B., Schneider E. Drug-induced apoptosis is not necessarily dependent on macromolecular synthesis or proliferation in the p53-negative human prostate cancer cell line PC-3. Cancer Res. 55:1995;2122-2128.
8. Hirata H., Takahashi A., Kobayashi S., Yonehara S., Sawai H., Okazaki T., Yamamoto K., Sasada M. Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis. J. Exp. Med. 187:1998;587-600.
9. Thomberry N.A., Lazebnik Y. Caspases: enemies within. Science. 281:1998;1312-1314.
10. Wang R., Zhang L., Yin D., Mufson R.A., Shi Y. Protein kinase C regulates Fas (CD9SIAPO-1) expression. J. Immunol. 161:1998;2201-2207.
11. Riiz-Riuz M.C., Izquierdo M., deMurcia G., Lopez-Rivas A. Activation of protein kinase C attenuates early signals in Fas-mediated apoptosis. Eur. J. Immun. 27:1997;1442-1450.
12. Hasusler P., Papoff G., Eramo A., Reif K., Cantrell D.A., Ruberti G. Protection of CD9S-mediated apoptosis by activation of phosphatidylinositide 3-kinase and protein kinase B. Eur. J. Immunol. 28:1998;57-69.
13. Takahashi H., Kobayasgi H., Hashimoto Y., Matsuo S., Iizuka H. Interferon-gamma-dependent stimulation of Fas antigen in 5V40-transformed human keratinocytes: modulatin of the apoptotic process by protein kinase C. J. Invest. Dermatol. 105:1995;810-815.
14. Leithäuser F., Dhein J., Mechtersheimer G., Koretz K., Brtiderlein S., Henne C., Schmidt A., Debatin K.M., Krammer P.H., Möller P. Constitutive and induced expression of APO-1, a new member of the nerve growth factor I tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Invest. 69:1993;415-429.
15. Wakahara Y., Nawa A., Okamoto T., Hayakawa A., Kikkawa E., Suganuma N., Wakahara F., Tomoda Y. Combination effect of anti-Fas antibody and chemotherapeutic drugs in ovarian cancer cells in vitro. Oncology. 54:1997;48-54.
16. Nicoletti I., Migliorati G., Pagliacci M.C., Grignani F., Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods. 139:1991;271-279.
17. Ohkusu K., Isobe K., Hidaka H., Nakashima I. Elucidation of the protein kinase C-dependent apoptosis pathway in distinct subsets of T lymphocytes in MRL-lpr/lpr mice. Eur. J. Immunol. 25:1995;3180-3186.
18. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J. Immunol. Methods. 65:1983;55-63.
19. Ally M.C., Sudiero D.A., Monks A., Hursey M.L., Czerwinsk M.J., Fine D.L., Abbott B.T., Maya J.G., Shoemaker R.H., Boyd M.R. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 48:1988;589-601.
20. Akhand A.A., Pu M., Du J., Kato M., Hamaguchi M., Nakashima I. Magnitude of protein tyrosine phosphorylation-linked signal determines growth versus death of thymic T lymphocytes. Eur. J. Immunol. 27:1997;1254-1259.
21. Jarvis W.D., Kolesnic R.N., Fornari F.A., Taraylor R.S., Gewirtz D.A., Grant S. Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc. Natl. Acad. Sci. USA. 91:1994;73-77.
22. Obeid L.M., Lindardic C.M., Karolak L.A., Hannun Y.A. Programmed cell death induced by ceramide. Science. 259:1993;1769-1771.
23. Pushkareva M., Obeid L.M., Hannun Y.A. Ceramide: an endogenous regulator of apoptosis and growth suppression. Immunol. Today. 16:1995;294-297.
24. Anel A., Buferne M., Boyer C., Schmit-Verhulst A.M., Golstein P. T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A. Eur. J. Immunol. 24:1994;2469-2476.
25. McCnkey D.J., Hartzell P., Jondal M., Orrenius S. Inhibition of DNA fragmentation in thymocytes and isolated thymocyte nuclei by agents that stimulate protein kinase C. J. Biol. Chem. 264:1989;13399-13402.
26. Ghayur T., Hugunin M., Talanian R.V. Proterolytic activation of protein kinase Cd by an ICE/CED 3-like protease induces characteristic of apoptosis. J. Exp. Med. 184:1996;2399-2404.
27. Illera V.A., Perandones C.E., Stunz L.L., Mower D.A. Jr, Ashman R.E. Apoptosis in splenic B lymphocytes. J. Immunol. 151:1993;2965-2973.